Cumberland Pharmaceuticals
CPIX
32 hedge funds and large institutions have $16M invested in Cumberland Pharmaceuticals in 2026 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 5 closing their positions.
99% more call options, than puts
Call options by funds: $1.72M | Put options by funds: $861K
78% more capital invested
Capital invested by funds: $8.97M → $16M (+$7.03M)
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
10% more funds holding
Funds holding: 29 → 32 (+3)
1.99% less ownership
Funds ownership: 18.46% → 16.48% (-2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$272K |
| 2 |
Jane Street
New York
|
+$202K |
| 3 |
B
Bailard
Foster City,
California
|
+$118K |
| 4 |
QC
Quadrature Capital
London,
United Kingdom
|
+$115K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$101K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$658K |
| 2 |
PA
Perceptive Advisors
New York
|
-$479K |
| 3 |
JGC
J. Goldman & Co
New York
|
-$263K |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$240K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$206K |
CPIX Hedge Fund Activity: Q2 2026 in Review
32 of the 8,317 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q2 2026, worth a combined $16M — up 78% from $8.97M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CPIX positions and 5 closed out — a net gain of 3 holders — while 10 added to existing stakes and 7 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $272K. The largest seller was Bridgeway Capital Management, cutting an estimated $658K.
- 32 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q2 2026, up from 29 in Q1 2026.
- Funds reported $16M of Cumberland Pharmaceuticals stock for Q2 2026, up 78% quarter-over-quarter.
- 8 funds opened new Cumberland Pharmaceuticals positions in Q2 2026 and 5 closed out, a net change of +3 holders.
- The largest Cumberland Pharmaceuticals buyer in Q2 2026 was Citadel Advisors, an estimated $272K added.
- The largest Cumberland Pharmaceuticals seller in Q2 2026 was Bridgeway Capital Management, an estimated $658K sold.
Based on aggregated 13F filings for Q2 2026.